CORMEDIX INC. Public Float
CORMEDIX INC. (CRMD) had Public Float of $909.70 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $909.70M.
- 2024-06-30: Entity Public Float $236.80M.
- 2023-06-30: Entity Public Float $180.00M.
- 2022-06-30: Entity Public Float $163.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $909.70M 10-K · filed 2026-03-05 |
| 2024-06-30 | $236.80M 10-K · filed 2025-03-25 |
| 2023-06-30 | $180.00M 10-K · filed 2024-03-12 |
| 2022-06-30 | $163.90M 10-K · filed 2023-03-30 |
| 2021-06-30 | $208.40M 10-K · filed 2022-03-29 |
| 2020-06-30 | $208.40M 10-K · filed 2021-03-30 |
| 2019-06-30 | $209.30M 10-K · filed 2020-03-16 |
| 2018-06-30 | $19.20M 10-K · filed 2019-05-29 |
| 2017-06-30 | $25.30M 10-K · filed 2018-03-19 |
| 2016-06-30 | $72.60M 10-K · filed 2017-03-16 |
| 2015-06-30 | $118.00M 10-K · filed 2016-03-15 |
| 2014-06-30 | $37.40M 10-K · filed 2015-03-12 |
| 2013-06-28 | $12.50M 10-K · filed 2014-03-31 |
| 2012-06-30 | $2.30M 10-K/A · filed 2014-03-04 |
| 2011-06-30 | $16.02M 10-K/A · filed 2012-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |